| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
GeneReach Biotechnology Corp (TWO: 4171)
4171 Technical Analysis
4
| As on 2nd Feb 2026 4171 STOCK Price closed @ 22.35 and we RECOMMEND Sell for LONG-TERM with Stoploss of 22.76 & Strong Sell for SHORT-TERM with Stoploss of 27.97 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4171STOCK Price
| Open | 21.45 | Change | Price | % |
| High | 23.00 | 1 Day | 0.50 | 2.29 |
| Low | 21.45 | 1 Week | 0.75 | 3.47 |
| Close | 22.35 | 1 Month | 2.80 | 14.32 |
| Volume | 656472 | 1 Year | -6.35 | -22.13 |
| 52 Week High 29.40 | 52 Week Low 16.95 | ||||
TWO Taiwan Most Active Stocks
| 5347 | 143.50 | -2.38% |
| 8096 | 76.30 | 9.94% |
| 1815 | 91.80 | 0.22% |
| 5351 | 61.20 | 0.99% |
| 4979 | 316.00 | -5.53% |
| 3221 | 30.10 | 7.50% |
| 3105 | 221.50 | -5.54% |
| 3163 | 456.00 | -3.49% |
| 8088 | 66.80 | 1.67% |
| 3260 | 331.00 | -8.94% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 4171 Daily Charts |
4171 Intraday Charts |
Whats New @ Bazaartrend |
4171 Free Analysis |
|
|
4171 Important Levels Intraday
| RESISTANCE | 25.34 |
| RESISTANCE | 24.38 |
| RESISTANCE | 23.79 |
| RESISTANCE | 23.19 |
| SUPPORT | 21.51 |
| SUPPORT | 20.91 |
| SUPPORT | 20.32 |
| SUPPORT | 19.36 |
4171 Forecast February 2026
| 4th UP Forecast | 32.18 |
| 3rd UP Forecast | 29.03 |
| 2nd UP Forecast | 27.08 |
| 1st UP Forecast | 25.13 |
| 1st DOWN Forecast | 19.57 |
| 2nd DOWN Forecast | 17.62 |
| 3rd DOWN Forecast | 15.67 |
| 4th DOWN Forecast | 12.52 |
4171 Weekly Forecast
| 4th UP Forecast | 24.08 |
| 3rd UP Forecast | 23.53 |
| 2nd UP Forecast | 23.18 |
| 1st UP Forecast | 22.84 |
| 1st DOWN Forecast | 21.86 |
| 2nd DOWN Forecast | 21.52 |
| 3rd DOWN Forecast | 21.17 |
| 4th DOWN Forecast | 20.62 |
4171 Forecast2026
| 4th UP Forecast | 51.45 |
| 3rd UP Forecast | 42.12 |
| 2nd UP Forecast | 36.35 |
| 1st UP Forecast | 30.58 |
| 1st DOWN Forecast | 14.12 |
| 2nd DOWN Forecast | 8.35 |
| 3rd DOWN Forecast | 2.58 |
| 4th DOWN Forecast | -6.75 |
GeneReach Biotechnology Corp ( TWO Taiwan Symbol : 4171 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4171 Business Profile
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology primarily in Taiwan. The company offers pathogen detection platforms, including equipment and reagents; and animal use medicines, biotechnology services, medical materials and equipment, and precision instruments. Its products are used in aquaculture, agriculture, food, companion animal, livestock, and human health industries. The company also provides polymerase chain reaction training programs, molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services. GeneReach Biotechnology Corp. was founded in 2004 and is headquartered in Taichung, Taiwan. Address: Central Taiwan Science Park, Taichung, Taiwan, 407
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service